S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.55
+1.87
+11.21%
ARVN · Arvinas, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
$7.56
-0.12
(-1.50%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$7.56
$7.54
$7.76
52-WEEK RANGE
$7.56
$6.74
$14.51
What's happening
- ARVN is down 1.50% today, trading at $7.56. — Live quote
- Volume today (43,396) is well below its 3-month average of 786,910. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.58 actual vs. $-0.38 estimated (+784.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 4
Buy 9
Hold 9
Sell 1
Strong sell 0
Aggregate ratings for 2026-10-01 (23 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
ARVN
-35.41%
vs S&P 500
-48.19%
1-YEAR RETURN
ARVN
-21.19%
vs S&P 500
-35.75%
6-MONTH RETURN
ARVN
-30.36%
3-MONTH RETURN
ARVN
-7.26%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$2.58
Est. $-0.38
BEAT +784.0%
2026-04-26 (Q1 2026)
$-0.90
Est. $-0.94
BEAT +4.0%
2026-01-26 (Q4 2025)
$-1.10
Est. $-0.60
MISS -82.7%
2025-10-26 (Q3 2025)
$-0.48
Est. $-0.81
BEAT +40.7%
Valuation Measures & Ratios
Enterprise Value4$399.7M
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)1.56
Price / Book70.95
EV4 / Revenue1.26
EV4 / EBITDA—
Profit Margin2.94%
Operating Margin-5.72%
Return on Equity (ROE8)1.91%
Return on Assets (ROA9)1.29%
Avg Volume (3M)786,910
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $546.3M | $679.0M | $623.0M | $536.6M | $509.8M |
| P/E | 35.24 | -9.56 | -9.95 | -8.56 | -7.19 |
| Price/Book | 0.97 | 1.76 | 1.10 | 0.88 | 0.77 |
| ROE | 2.76% | -18.36% | -11.09% | -10.29% | -10.74% |
| ROA | 2.30% | -10.97% | -7.41% | -6.90% | -7.08% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short5,389,277
Change from Prior Settlement+8.08%
% of Float—
Days to Cover (Short Ratio)6.58
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 1014.7% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 10-Q, filed 2026-08-04; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 2.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -21.2%. Finnhub market metrics ↗
- Trailing P/E is 53.1, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on ARVN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $249.7M | $15.6M | — | $22.4M | $188.8M | — | — | — |
| Operating income | $164.1M | -$63.8M | -$43.8M | -$71.5M | $71.4M | -$60.3M | -$48.5M | -$83.3M |
| Net income | $169.4M | -$57.6M | -$35.1M | -$61.2M | $82.9M | -$49.2M | -$35.2M | -$69.4M |
| EPS (diluted) | $2.58 | $-0.90 | $-0.48 | $-0.84 | $1.14 | $-0.68 | $-0.49 | $-0.97 |
| EPS (basic) | $2.61 | $-0.90 | $-0.48 | $-0.84 | $1.14 | $-0.68 | $-0.49 | $-0.97 |
| Operating margin | $66 | -$409 | — | -$319 | $38 | — | — | — |
| Net margin | $68 | -$369 | — | -$273 | $44 | — | — | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $675.1M | $647.5M | $717.9M | $844.3M | $909.3M | $1.00B | $1.09B | $1.17B |
| Total liabilities | $112.9M | $260.7M | $284.0M | $279.9M | $300.0M | $341.0M | $529.7M | $581.1M |
| Stockholders' equity | $562.2M | $386.8M | $433.9M | $564.4M | $609.3M | $660.1M | $561.7M | $586.0M |
| Total current assets | $652.2M | $630.7M | $700.7M | $826.3M | $889.5M | $979.7M | $1.07B | $1.15B |
| Total current liabilities | $82.5M | $115.9M | $142.5M | $144.9M | $157.8M | $214.0M | $229.8M | $275.9M |
| Cash & equivalents | $94.3M | $87.3M | $142.9M | $101.5M | $114.9M | $81.0M | $100.5M | $85.2M |
| Marketable securities (current) | $473.6M | $527.6M | $542.5M | $686.1M | $746.3M | $873.3M | $938.9M | $1.04B |
| Accounts receivable | $50.3M | $1.8M | $1.0M | $20.3M | $500.0K | $400.0K | $5.7M | $7.3M |
| Property, plant & equipment | $5.0M | $5.5M | $5.2M | $5.4M | $6.1M | $6.7M | $7.0M | $6.8M |
| Other non-current assets | — | — | — | — | — | — | — | — |
| Accounts payable | $7.5M | $31.4M | $24.4M | $18.0M | $16.6M | $26.4M | $13.4M | $17.7M |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Deferred revenue (current) | $0 | $51.8M | $71.3M | $87.7M | $102.9M | $141.0M | $156.2M | $199.2M |
| Short-term debt | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K |
| Long-term debt | $300.0K | $300.0K | $400.0K | $400.0K | $500.0K | $500.0K | $600.0K | $600.0K |
| Other non-current liabilities | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K |
| Retained earnings | -$1.50B | -$1.67B | -$1.61B | -$1.54B | -$1.51B | -$1.45B | -$1.53B | -$1.49B |
| Accumulated other comprehensive income (loss) | -$800.0K | -$400.0K | $1.2M | $1.4M | $1.0M | $1.5M | $1.0M | $4.1M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$48.3M | -$69.2M | -$30.4M | -$59.1M | -$95.4M | -$88.9M | -$84.1M | -$128.0M |
| Investing cash flow | $54.9M | $13.7M | $145.8M | $63.5M | $128.8M | $69.5M | $98.9M | $50.5M |
| Financing cash flow | $400.0K | -$100.0K | -$74.0M | -$17.8M | $500.0K | -$100.0K | $500.0K | $2.4M |
| Free cash flow | -$48.5M | -$70.5M | -$30.6M | -$59.2M | -$96.6M | -$89.3M | -$84.4M | -$128.7M |
| Capital expenditures | $200.0K | $1.3M | $200.0K | $100.0K | $1.2M | $400.0K | $300.0K | $700.0K |
| Share-based compensation | $5.9M | $12.1M | $8.5M | $10.2M | $10.3M | $15.0M | $23.3M | $24.7M |
| Deferred income taxes | — | — | $0 | — | — | — | $0 | — |
| Change in accounts receivable | $48.5M | $800.0K | -$19.3M | $19.8M | $100.0K | -$5.3M | -$1.6M | $7.3M |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Purchases of investments | $60.4M | $178.9M | $6.6M | $110.0M | $118.0M | $119.6M | $51.3M | $160.4M |
| Share repurchases | — | — | $74.1M | $17.8M | — | — | $0 | $0 |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | $100.0K | $100.0K | $100.0K | $0 | $0 | $100.0K | $100.0K | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | $46.7M |
| Operating income | -$118.5M | -$250.2M | -$401.5M | -$263.2M | -$188.4M |
| Net income | -$80.8M | -$198.9M | -$367.3M | -$282.5M | -$191.0M |
| EPS (diluted) | $-1.14 | $-2.77 | $-6.62 | $-5.31 | $-3.82 |
| EPS (basic) | $-1.14 | $-2.77 | $-6.62 | $-5.31 | $-3.82 |
| Operating margin | — | — | — | — | -$403 |
| Net margin | — | — | — | — | -$409 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $717.9M | $1.09B | $1.30B | $1.27B | $1.58B |
| Total liabilities | $284.0M | $529.7M | $644.6M | $703.9M | $799.9M |
| Stockholders' equity | $433.9M | $561.7M | $660.0M | $564.9M | $781.7M |
| Total current assets | $700.7M | $1.07B | $1.28B | $1.24B | $1.55B |
| Total current liabilities | $142.5M | $229.8M | $257.1M | $295.1M | $261.7M |
| Cash & equivalents | $142.9M | $100.5M | $311.7M | $81.3M | $108.3M |
| Marketable securities (current) | $542.5M | $938.9M | $949.3M | $1.12B | $1.39B |
| Accounts receivable | $1.0M | $5.7M | $0 | $1.0M | $15.0M |
| Property, plant & equipment | $5.2M | $7.0M | $11.5M | $13.4M | $12.7M |
| Other non-current assets | — | — | — | — | — |
| Accounts payable | $24.4M | $13.4M | $17.8M | $5.7M | $31.3M |
| Accrued liabilities | — | — | — | — | $23.1M |
| Deferred revenue (current) | $71.3M | $156.2M | $163.0M | $218.6M | $206.2M |
| Short-term debt | $200.0K | $200.0K | $200.0K | $0 | — |
| Long-term debt | $400.0K | $600.0K | $800.0K | $1.0M | $1.0M |
| Other non-current liabilities | — | — | — | — | — |
| Common stock & paid-in capital | $100.0K | $100.0K | $100.0K | $100.0K | $0 |
| Retained earnings | -$1.61B | -$1.53B | -$1.33B | -$965.4M | -$682.9M |
| Accumulated other comprehensive income (loss) | $1.2M | $1.0M | -$3.1M | -$19.2M | -$4.6M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$273.8M | -$259.3M | -$347.8M | -$273.5M | $559.4M |
| Investing cash flow | $407.6M | $34.7M | $203.5M | $242.8M | -$1.31B |
| Financing cash flow | -$91.4M | $7.9M | $374.7M | $4.7M | $278.6M |
| Free cash flow | -$275.7M | -$261.1M | -$350.7M | -$280.3M | $554.7M |
| Capital expenditures | $1.9M | $1.8M | $2.9M | $6.8M | $4.7M |
| Share-based compensation | $44.0M | $88.2M | $71.6M | $75.5M | $57.1M |
| Deferred income taxes | $0 | $0 | $0 | $0 | $0 |
| Change in accounts receivable | -$4.7M | $5.7M | -$1.0M | -$14.0M | $14.0M |
| Change in accounts payable | — | — | — | — | $23.7M |
| Purchases of investments | $354.2M | $652.1M | $956.3M | $886.4M | $1.74B |
| Share repurchases | $91.9M | $0 | $0 | — | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | $200.0K | $400.0K | $0 | $0 | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding ARVN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Insider activity is not available for this symbol right now.
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 09:14 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-26 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-25 | 8-K | 2026-06-24 | View on SEC.gov → |
| 2026-06-24 | 4 | 2026-06-24 | View on SEC.gov → |
| 2026-06-22 | 8-K | 2026-06-22 | View on SEC.gov → |
| 2026-06-18 | 4 | 2026-06-17 | View on SEC.gov → |
Recent news
Headlines about ARVN (Arvinas, Inc.). Links open the publisher — we don’t host full articles.
-
ARVN Jan 2027 7.000 put (ARVN270115P00007000) stock price, news, quote and history
Yahoo Finance UK · 2026-10-21 -
Why (ARVN) Price Action Is Critical for Tactical Trading
Stock Traders Daily · 2026-10-20 -
Arvinas, Inc. (ARVN) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-20 -
Arvinas, Inc. (ARVN) stock price, news, quote and history
Yahoo Finance UK · 2026-10-20 -
Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
Yahoo Finance · 2026-10-19 -
ARVN Stock Drops On CEO Exit — Retail Is Bullish On New Chief’s Credentials, Dismisses Selloff
Stocktwits · 2026-10-17 -
Arvinas Stock Price Forecast. Should You Buy ARVN?
StockInvest.us · 2026-10-16 -
Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease
Yahoo Finance · 2026-10-16
No headlines in this category right now — try “All”.